$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week


Prev. Close
About Frequency Therapeutics, Inc.
Frequency Therapeutics, Inc. is a clinical-stage biotechnology company. It engages in the development of small molecule drugs that activate progenitor cells within the body to restore healthy tissue. The company was founded by Robert S. Langer, Jr., David L. Lucchino, Christopher Loose and Will J. McLean in November 13, 2014 and is headquartered in Woburn, MA.
Sector
Commercial Services
CEO
David L. Lucchino
Industry
Miscellaneous Commercial Services
Exchange
NASDAQ
Website
Top Stories
Coming soon.